21 Nov
|
Dr. Reddy's Laboratories
|
Hyderabad
21 Nov
Dr. Reddy's Laboratories
Hyderabad
Job Description
Role Purpose
Lead enterprise portfolio choices BD-led asset selection and , strategy by translating long-term ambition into executable priorities, identifying differentiated opportunities and ensuring disciplined delivery through launch and value realization.
Role Profile
- Reports to: Head - Portfolio and Strategy, India Business
- Team size: 4–5 team members
- Stakeholder ecosystem: Biologics (Clinico-Regulatory), India Business Cluster Heads, CEO - India Business, Business Development and Finance
A. Portfolio
Team Leadership & Therapy-Area Ownership
- Lead and develop portfolio team members assigned to defined therapy areas, ensuring clear ownership of Disease Area strategy, opportunity identification, asset evaluation, prioritization and portfolio progression.
TA Strategy & Portfolio Gap Definition
- Lead Disease Area refreshes and translate unmet needs, evolving standards of care and treatment changes into portfolio priorities.
- Define therapy-area aspirations, ideation gaps and indication-expansion opportunities.
Asset Evaluation & Prioritization
- Assess clinical differentiation, patient opportunity, commercial fit, competition, patents, FTO and exclusivity.
- Prioritize assets and maintain a balanced roadmap of high-value opportunities.
BD / In-Licensing Route Strategy
- Compare BD, in-house and third-party routes based on value, complexity, cost, timeline, supply control and exclusivity.
- Recommend preferred and contingency routes with clear rationale and switch triggers.
BD Partnering & Opportunity Enablement
- Enable partner mapping, competitive assessment, diligence and investment rationale for active pursuits.
- Provide differentiated alternatives and maintain decision cases for priority opportunities.
BD Asset Selection & Clinico-Regulatory Strategy
- Map opportunities to divisions and co-create clinico-regulatory strategy for innovative and BD assets.
- Lead cross-functional diligence through NBTS and track selection, signing and closure conditions.
Competitive Intelligence & Strategic Watchlist
- Monitor regulatory, clinical, patent and competitor developments and maintain the asset watchlist.
- Convert intelligence into timely changes in priority, route, forecast, timing and risk mitigation.
Portfolio & New-Product Program Governance
- Govern selected assets across development, registration, sourcing, supply and launch readiness.
- Track execution dependencies, risks, decisions and actions through closure.
B. Strategy
Team Leadership & Strategy Partnering
- Lead, develop and deploy a team of Strategy Business Partners to support business units and therapy areas in strategic planning, execution governance, performance reviews and delivery of priority initiatives.
Strategy Planning & Long-Term Aspiration
- Lead annual and multi-year strategic planning, translating enterprise, cluster and therapy-area ambition into integrated value, volume and business priorities.
- Align top-down aspirations with bottom-up market, brand and functional inputs; define guardrails for resource allocation, sequencing and trade-offs.
Growth Strategy & Strategic Initiatives
- Identify new growth spaces, therapy areas, channels, markets, partnerships and business models.
- Build business cases and Go / No-Go recommendations; pilot and scale approved concepts with clear success and exit criteria.
Market Intelligence, Foresight & Scenario Planning
- Develop market forecasts, strategic scenarios and early-warning indicators; test plan resilience under alternative futures.
Brand Performance, RCA & Countermeasures
- Identify underperforming or strategically critical brands using market, performance, execution and capability indicators.
- Lead cross-functional root-cause analysis and govern countermeasures across Commercial, Medical, Supply and enabling functions.
Strategic Execution & Performance Management
- Convert strategic moves into projects and SDPs with clear scope, ownership, outcomes and cross-functional dependencies.
- Track milestones, risks, course correction and benefits realization, including central productivity and leadership priorities.
Business Governance, PMO & Annual Planning
- Own leadership-review governance, brand and portfolio planning, budgeting alignment and execution readiness.
- Convert approved priorities into initiatives, milestones, KPIs and dependencies; program-manage delivery through benefit realization and closure.
Cluster Priority & New-Product Governance
- Program-manage cluster priorities, including M&A; opportunities and new launches, through an integrated cross-functional PMO.
- Own new-product governance across opportunity, forecast, investment, readiness, execution, post-launch recalibration and learning.
Key Outcomes
- Integrated long-term strategy translated into executable priorities.
- Disciplined delivery of strategic initiatives and growth programs.
- Prioritized, risk-mitigated portfolio with explicit BD routes and partner options.
- Selected assets governed through diligence, development and launch readiness.
- Market and competitive intelligence converted into timely strategic and portfolio actions.
📌 Head Portfolio Ideation and Therapy Strategy (Hyderabad)
🏢 Dr. Reddy's Laboratories
📍 Hyderabad